Sridevi Addanki

494 citations
8 papers · 266 indexed · h-index 5
Topics
Cancer Cells and Metastasis (3 papers)Cholesterol and Lipid Metabolism (2 papers)Drug Transport and Resistance Mechanisms (2 papers)
Partner nations
United StatesSwedenChina

In The Last Decade

Sridevi Addanki

8 papers receiving 264 citations

Peers

Sridevi Addanki
Comparison fields: 5 of 53
  • Molecular Biology 150
  • Cancer Research 121
  • Oncology 111
  • Surgery 56
  • Pulmonary and Respiratory Medicine 44
Replace Giórgia Gobbi da Silveira with:
Giórgia Gobbi da Silveira Brazil
Shunsuke Ebara Japan
Verónica Moncho-Amor Spain
Yongchu Sun China
Jian-chuan Xia China
Ying-Hui Zhu China
Junwei Fan China
Jinxue Tong China
Ruizhe Shen China
Subhasree Balakrishnan United States
Sridevi Addanki relative to Giórgia Gobbi da Silveira Brazil Giórgia Gobbi da Silveira's profile →
Citations per field
00.5×1.5×
Giórgia Gobbi da Silveira · 1×
Citations per year

Countries citing papers authored by Sridevi Addanki

Since Specialization
Citations

This map shows the geographic impact of Sridevi Addanki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridevi Addanki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridevi Addanki more than expected).

Fields of papers citing papers by Sridevi Addanki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sridevi Addanki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridevi Addanki. The network helps show where Sridevi Addanki may publish in the future.

Co-authorship network of co-authors of Sridevi Addanki

This figure shows the co-authorship network connecting the top 25 collaborators of Sridevi Addanki. A scholar is included among the top collaborators of Sridevi Addanki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridevi Addanki. Sridevi Addanki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 3
2 3
3 3
4 28
5 12
6 131
7 16
8 70

About Sridevi Addanki

Sridevi Addanki is a scholar working on Cancer Research, Oncology and Hematology, having authored 8 papers that have together received 266 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Cancer Research (121 citations), Oncology (111 citations) and Molecular Biology (150 citations). Sridevi Addanki has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include Rama Soundararajan, Robiya Joseph, Abhijeet Deshmukh, Petra den Hollander, Nick A. Kuburich, Suhas Vasaikar, Sendurai A. Mani, Jeffrey T. Chang, Chin‐Yo Lin and Jan-Ακε Gustafsson. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026